Sign up for Table of Contents Alerts.
Email this page
Print this page
Bedside to Bench
Clinicopathologic and Molecular Features of Hodgkin Lymphoma
Anas Younes and Antonino Carbone
volume 2 | issue 5
sept/oct 2003Pages: 500-507
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Hodgkin lymphoma is a relatively uncommon malignancy that predominantly effects young adults. It became the first human cancer to be cured with combination chemotherapy. Unfortunately, many cured patients do not live their expected lifespan because of long-term lethal effects of therapy. Novel treatment strategies based on our understanding of Hodgkin lymphoma biology are currently being explored to maintain the high cure rate without the added treatment related toxicity.
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.